BioSpace News Archive

Alimera Sciences, Inc. announces that clinical data for ILUVIEN® 0.19 mg and YUTIQ® 0.18 mg will be featured in five presentations during the Retina Society’s 56th Annual Scientific Meeting being held in New York City from October 11-14, 2023.

NKGen Biotech Inc. announced an upcoming poster presentation on an interim report of a Phase I study of SNK01 in patients with Alzheimer’s Disease, at the XXVI World Congress of Neurology Annual Meeting to be held in Montreal, QC, Canada and online between October 15–19, 2023.

Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine Congress Europe 2023 in Barcelona, Spain on Wednesday, October 18 and Thursday, October 19, 2023.

Rezolute, Inc. announced results following administration of RZ358 to a patient with refractory hypoglycemia due to tumor-mediated hyperinsulinism on a compassionate-use basis, under its expanded access program.

Boehringer Ingelheim Ltd. and BI X, the digital lab of Boehringer Ingelheim, have collaborated to introduce a new digital clinical support tool for Canadian healthcare professionals managing the care of individuals with type 2 diabetes mellitus.

Arbutus Biopharma Corporation announced that clinical data from the Company’s lead HBV focused asset, imdusiran, an RNAi therapeutic, and preclinical data from its oral PD-L1 inhibitor program, will be highlighted in oral and poster presentations, including a late breaking poster presentation at The AASLD – The Liver Meeting® 2023.

Kintara Therapeutics, Inc. announced that its President and CEO, Robert E. Hoffman will present at the 8th Annual Dawson James Small Cap Growth Conference on Thursday, October 12, 2023 at 10:30 am ET.

STRM.BIO presented the first preclinical data on the company’s novel delivery platform for in vivo gene therapy that uses megakaryocyte-derived EVs to target bone marrow hematopoietic stem cells at the 2023 Cell & Gene Meeting on the Mesa being held in Carlsbad, California.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will present study findings during two posters sessions at IDWeek 2023, October 11-15.

Kodiak Sciences Inc. announced that three scientific presentations on tarcocimab tedromer, including a first-time presentation of the primary results from the Phase 3 DAYLIGHT study in wet age-related macular degeneration.